HeraMED (ASX:HMD) Other Current Receivables: A$0.04 Mil (As of Dec. 2025)


What is HeraMED Other Current Receivables?

HeraMED ASX:HMD -2.50% Other Current Receivables is A$0.04 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

HeraMED's Other Current Receivables for the quarter that ended in Dec. 2025 was A$0.04 Mil.

HeraMED's quarterly Other Current Receivables declined from Dec. 2024 (A$0.13 Mil) to Jun. 2025 (A$0.00 Mil) but then increased from Jun. 2025 (A$0.00 Mil) to Dec. 2025 (A$0.04 Mil).

HeraMED's annual Other Current Receivables declined from Dec. 2023 (A$0.30 Mil) to Dec. 2024 (A$0.13 Mil) and declined from Dec. 2024 (A$0.13 Mil) to Dec. 2025 (A$0.04 Mil).

HeraMED Other Current Receivables Related Terms

HeraMED Other Current Receivables Historical Data

* Premium members only.

The historical data trend for HeraMED's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeraMED Other Current Receivables Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 0.33 0.36 0.30 0.13 0.04

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.00 0.13 0.00 0.04

HeraMED Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of A$0.04 Mil mean?
HeraMED (ASX:HMD) has a Other Current Receivables of A$0.04 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on HeraMED and its competitors.
Is HeraMED's Other Current Receivables too high?
HeraMED's current Other Current Receivables is A$0.04 Mil.
How does HeraMED's Other Current Receivables compare to ABT and SYK?
HeraMED's Other Current Receivables of A$0.04 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on HeraMED and its competitors. HeraMED's current Other Current Receivables is A$0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeraMED stock overvalued right now?
Based on GuruFocus' analysis, HeraMED (ASX:HMD) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.04 — trading 95% above its estimated fair value. The current Other Current Receivables is A$0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For HeraMED (ASX:HMD), the current Other Current Receivables is A$0.04 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeraMED Business Description

Other Exchanges 1I4:Germany
Address 117 Camberwell Road, Level 1 - Suite 1, Hawthorn East, Melbourne, VIC, AUS, 3123
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.